Data updated: Mar 29, 2026

PACO

Oncology

Generics

PACO is a generic drug manufacturer focused on Oncology.

1989

Since

5

Drugs

-

Trials

13

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

LIDOCAINE HYDROCHLORIDE 2025-10-02

Manufacturing (CMC)

LIDOCAINE HYDROCHLORIDE 2025-09-26

LIDOCAINE HYDROCHLORIDE 2025-08-27

Manufacturing (CMC)

LIDOCAINE HYDROCHLORIDE 2025-08-22

LIDOCAINE HYDROCHLORIDE 2025-08-22

METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01

METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01

LIDOCAINE HYDROCHLORIDE 2025-07-29

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 100%

0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

Baxter specialty

AbbVie big-pharma